Interpace Biosciences, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | 49.0% | 106.6% | 67.1% |
| Jun 2017 | 51.3% | -93.3% | -165.8% |
| Sep 2017 | 50.8% | -73.7% | -80.9% |
| Dec 2017 | 62.5% | -75.5% | 458.0% |
| Mar 2018 | 46.4% | -67.5% | -68.1% |
| Jun 2018 | 59.2% | -34.5% | -36.4% |
| Sep 2018 | 52.0% | -42.8% | -54.3% |
| Dec 2018 | 55.3% | -86.1% | -73.7% |
| Mar 2019 | 56.4% | -53.0% | -55.3% |
| Jun 2019 | 51.7% | -85.3% | -84.6% |
| Sep 2019 | 37.4% | -92.3% | -96.4% |
| Dec 2019 | -28.1% | -255.6% | -253.0% |
| Mar 2020 | 32.5% | -70.1% | -71.7% |
| Jun 2020 | 29.3% | -106.0% | -102.5% |
| Sep 2020 | 37.0% | -72.8% | -75.6% |
| Dec 2020 | 32.4% | -82.3% | -84.4% |
| Mar 2021 | 45.9% | -38.8% | -42.8% |
| Jun 2021 | 48.0% | -26.1% | -30.9% |
| Sep 2021 | 55.1% | -22.7% | -44.2% |
| Dec 2021 | -21.6% | -10.6% | 17.9% |
| Mar 2022 | 189.8% | -39.8% | -91.6% |
| Jun 2022 | 195.8% | -97.9% | -201.4% |
| Sep 2022 | 373.5% | -61.6% | -1,121.4% |
| Dec 2022 | 501,100.0% | 5,400.0% | -156,400.0% |
| Mar 2023 | 63.6% | 8.7% | 5.3% |
| Jun 2023 | 65.4% | 11.0% | 5.1% |
| Sep 2023 | 58.5% | 4.5% | -2.0% |
| Dec 2023 | 62.3% | 14.7% | 10.5% |
| Mar 2024 | 62.0% | 10.9% | 7.0% |
| Jun 2024 | 64.8% | 21.9% | 20.2% |
| Sep 2024 | 64.3% | 18.7% | 13.6% |
| Dec 2024 | 63.7% | 16.6% | 15.2% |
| Mar 2025 | 64.0% | 15.9% | 14.3% |
| Jun 2025 | 57.1% | -5.1% | -6.9% |
| Sep 2025 | 62.1% | 13.1% | 10.4% |
| Dec 2025 | 65.5% | 17.1% | 245.6% |
| Mar 2026 | 65.4% | 12.4% | 8.0% |
| Jun 2026 | 61.9% | 3.5% | 1.7% |